Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT03209713

Edtech-HPV: A Community Approach Using Education and Technology to Increase HPV Vaccination

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
672 (actual)
Sponsor
Memorial Sloan Kettering Cancer Center · Academic / Other
Sex
All
Age
21 Years – 84 Years
Healthy volunteers
Accepted

Summary

This study is a two-arm randomized controlled trial, implemented to assess the effectiveness of a community-based educational program with and without a text messaging reminder system, in increasing the rate of HPV vaccination completion among children of Mexican Americans. The investigator's have extended the duration that participants are followed in assessing their child's uptake of the HPV vaccine to coincide with the COVID-19 related clinic closures and/or allow flexibility for participants who decide to delay their child's vaccination for fear of exposure to the COVID-19 infection. A survey will also assess the participants concerns regarding the impact COVID-19 has had in their daily life, such as financial insecurity, food access, housing insecurity and among other most common concerns during this unprecedented time. Additional navigation, referrals and interviewer notes will also be captured. Participants may be called by site or MSK staff to complete study surveys and will be informed verbally or by a mailed letter.

Conditions

Interventions

TypeNameDescription
BEHAVIORALHPV Vaccine EducationA one on one twenty-minute parental educational program (in-person or over the phone) providing facts about HPV, HPV-related cancers, and the HPV vaccine.
BEHAVIORALText Messaging ReminderParticipants will receive a text message reminding them of their child's vaccination eligibility once a week, starting one week after participating in the education session (in-person or over the phone). All participants randomized to the text message reminder arm will receive a welcome text message from the automated web-based text messaging service, Mosio, within 72 hours from registration. One week after receiving the welcome text message, they will receive the first weekly text messages reminding them of their child's eligibility for the first dose HPV vaccine. These weekly reminders will occur until uptake of the first dose of the vaccine is reported (through self-report outcome survey completion or submission of the HPV vaccination card/child's official immunization card) or for up to 12 weeks

Timeline

Start date
2017-06-28
Primary completion
2026-06-01
Completion
2026-06-01
First posted
2017-07-06
Last updated
2025-04-17

Locations

4 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT03209713. Inclusion in this directory is not an endorsement.